Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
BIO-B — Bio-Rad Laboratories, Inc.
NYSE
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 4, 2026
REVENUE
$651.0M +9.9%
NET MARGIN
57.1% +146.1 PTS
EPS
$13.89 +171.0%
FREE CASH FLOW
$66.7M -14.6%

No summary has been written for this call yet.